Interaction between enantiomers of mianserin and ORG3770 at 5-HT3 receptors in cultured mouse neuroblastoma cells
- 30 April 1994
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 33 (3-4) , 501-507
- https://doi.org/10.1016/0028-3908(94)90081-7
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Differential binding characteristics of agonists at 5-HT3 receptor recognition sites in NG108-15 neuroblastoma-glioma cells labelled by and [3H]granisetronBiochemical Pharmacology, 1993
- Common pharmacological and physico-chemical properties of 5-HT3 binding sites in the rat cerebral cortex and NG 108-15 clonal cellsBiochemical Pharmacology, 1990
- Characterization of 5-HT3 receptors in intact N1E-115 neuroblastoma cellsEuropean Journal of Pharmacology: Molecular Pharmacology, 1990
- Interaction of psychotropic drugs with central 5-HT3 recognition sites: fact or artifact?European Journal of Pharmacology, 1989
- Neurochemical and autonomic pharmacological profiles of the 6-aza-analogue of mianserin, org 3770 and its enantiomersNeuropharmacology, 1988
- Identification and distribution of 5-HT3 receptors in rat brain using radioligand bindingNature, 1987
- Stereoselective blockade of central [3H]5-hydroxytryptamine binding to multiple sites (5-HT1A, 5-HT1B and 5-HT1C) by mianserin and propranololJournal of Pharmacy and Pharmacology, 1987
- Properties of internally perfused, voltage-clamped, isolated nerve cell bodies.The Journal of general physiology, 1978
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973
- An Algorithm for Least-Squares Estimation of Nonlinear ParametersJournal of the Society for Industrial and Applied Mathematics, 1963